Prospective clinical trial on the influence of 1,25(OH)2D3 plasma concentrations on implantation in IVF/ICS-patients
- Conditions
- Pregnancy rate in IVF/ICSI patients
- Registration Number
- DRKS00014967
- Lead Sponsor
- Department für Frauengesundheit
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 87
Inclusion Criteria
Age between 18 and 45 years (inclusively)
- Indication for IVF/ICSI treatment
- ability and will to meet study conditions
- Informed consent after information
Exclusion Criteria
- Known systemic diseases being influenced by vitamine D such as inflammatory diseases or malignic dieseases
- Patients declining participation
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Aim of this monocentric, prospektive study ist to investigate the Influence of 1,25(OH)2D3 plasma concentrations on the implantation in patients with IVF/ICSI treatment
- Secondary Outcome Measures
Name Time Method